trimebutine has been researched along with Spastic Paraplegia, Hereditary in 1 studies
Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.
Spastic Paraplegia, Hereditary: A group of inherited diseases that share similar phenotypes but are genetically diverse. Different genetic loci for autosomal recessive, autosomal dominant, and x-linked forms of hereditary spastic paraplegia have been identified. Clinically, patients present with slowly progressive distal limb weakness and lower extremity spasticity. Peripheral sensory neurons may be affected in the later stages of the disease. (J Neurol Neurosurg Psychiatry 1998 Jan;64(1):61-6; Curr Opin Neurol 1997 Aug;10(4):313-8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loers, G | 1 |
| Appel, D | 1 |
| Lutz, D | 1 |
| Congiu, L | 1 |
| Kleene, R | 1 |
| Hermans-Borgmeyer, I | 1 |
| Schäfer, MKE | 1 |
| Schachner, M | 1 |
1 other study available for trimebutine and Spastic Paraplegia, Hereditary
| Article | Year |
|---|---|
Amelioration of the abnormal phenotype of a new L1 syndrome mouse mutation with L1 mimetics.
Topics: Animals; Cells, Cultured; Cerebellum; Cerebral Ventricles; Corpus Callosum; Duloxetine Hydrochloride | 2021 |